Drugmaker Pfizer on Friday sued obesity-drug developer Metsera and Novo Nordisk, seeking to block Metsera from terminating ...
Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based ...
Risks and uncertainties relating to Pfizer's proposed acquisition of Metsera include ... price of the Company's common stock and the impact of the litigation on Novo Nordisk's unsolicited proposal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback